Interventional Trial of Vitamin D Deficiency in the Patients of General Departments
Vitamin D Deficiency in the Elder Patients of General Departments and Its Treatment During the Hospitalization
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
Today vitamin D is thought to be one of the most important vitamins in the human body. It's made in the skin during the sun expose, so it must be sufficient in so sunny countries as Israel. Although many old people in our country suffer from vitamin d deficiency which bring them to recurrent falls, osteoporotic fractures and physical disability. This problem is still underestimated by health authorities in different countries.
In this study we will examine the vitamin D state of the therapeutic patient older than 65 year including their physical self-estimation, muscle strength measurement and gait-and-balance tests. Then, according to the resent studies, we will treat the patients in the interventional group with two large doses of vitamin D during a month. After that we will compere their health and physical state with the patients treated in the out-hospital department.
So we will try to find a useful approach to treat the vitamin D deficiency during the hospitalization.
Type d'étude
Inscription (Anticipé)
Phase
- Phase 3
Contacts et emplacements
Lieux d'étude
-
-
-
Haifa, Israël
- Recrutement
- Rambam Health Care Campus
-
Sous-enquêteur:
- Nodelman Marina, MD
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- the patient was admitted to a general department of Rambam Medical Center for any reason from March to May 2008
- the patient is 65 years old or older
- the patient is in a good health, based on medical history, physical examination and laboratory screening evaluation.
Exclusion Criteria:
- renal failure with creatinine level more then 1.3 mg/dL or nephritic syndrome.
- liver disease with transaminase rise three times from normal level.
- nephrolithiasis in the last fife years.
- primary hyperparathyroidism, hypoparathyroidism or pseudohypoparathyroidism.
- advanced cancer.
- chronic diarrhea or malabsorption.
- granulomatous disease (sarcoidosis, tuberculosis, lymphoma).
- patients, who are receiving barbiturates, rifampin, anticonvulsants.
- patients, who are receiving digitalis.
- patients, who are receiving glucocorticoids for more than two weeks during the study.
- advanced dementia.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Non randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: 1
Arm 1 - the patients will receive two large doses of vitamin D.
|
We will use the vitamin alpha-D3 drops of CTS pharmaceutical firm , that contains 5000 IU in ml.
Every patient in the interventional group will receive two dose of 100000 IU (20 ml)vitamin alpha-D3 within a month period.
Autres noms:
|
|
Aucune intervention: 2
Arm 2 - the patients vitamin D status will be checked during the hospitalization and they will receive the recommendation to treat the vitamin D deficiency in the out-patient department.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
vitamin D status
Délai: two month
|
two month
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
physical performance, health conditions, arm strength, gait and balance state.
Délai: two month
|
two month
|
Collaborateurs et enquêteurs
Parrainer
Les enquêteurs
- Chercheur principal: Ish-Shalom Sofia, Professor, Rambam Health Care Campus
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Estimation)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- VD-1.CTIL
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .